tradingkey.logo
tradingkey.logo
Search

Amneal Pharmaceuticals Inc

AMRX
Add to Watchlist
18.320USD
-0.180-0.97%
Close 07-31 16:00ETQuotes delayed by 15 min
5.76BMarket Cap
47.25P/E TTM

Amneal Pharmaceuticals Inc

18.320
-0.180-0.97%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.97%

5 Days

+2.23%

1 Month

+7.96%

6 Months

+33.92%

Year to Date

+45.40%

1 Year

+133.97%

Key Figures
18.170Open
18.430High
2.01MVolume
47.25P/E TTM
13.97P/E Dynamic
--Dividend TTM
0.64%Turnover Ratio
18.500Prev. Close
17.920Low
27.47MTurnover
LossP/E Static
-81.40P/B
0.00%Div Yield TTM
5.25%ROA
15.42052wk High
1.07Volume Ratio
-116.89MNet Profit
314.56MShares
0.3877EPS TTM
1.31Beta
-155.38%ROE
7.07052wk Low
2.76%Amplitude
42.01%Gross Margin
5.76BMarket Cap
4.83Reward/Risk
1.93%Risk Rate

Key Insights

Amneal Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 37 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.84.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Amneal Pharmaceuticals Inc's Score

Industry at a Glance

Industry Ranking
37 / 155
Overall Ranking
89 / 4281
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Amneal Pharmaceuticals Inc Highlights

StrengthsRisks
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.12% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 47.25, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 161.64M shares, decreasing 13.73% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 21.70K shares of this stock.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
18.844
Target Price
-1.34%
Upside Space

Amneal Pharmaceuticals Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 5 analysts
Buy
Current Rating
18.844
Target Price
-1.34%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Amneal Pharmaceuticals Inc
AMRX
5
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32

Indicators

Indicators
Sell(3)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.023
Neutral
RSI(14)
61.004
Neutral
STOCH(KDJ)(9,3,3)
60.965
Sell
ATR(14)
0.656
Low Volatility
CCI(14)
50.310
Neutral
Williams %R
35.075
Buy
TRIX(12,20)
0.540
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
18.554
Sell
MA10
18.201
Buy
MA20
17.697
Buy
MA50
16.059
Buy
MA100
14.331
Buy
MA200
13.482
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Amneal Pharmaceuticals Inc Info

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Ticker SymbolAMRX
CompanyAmneal Pharmaceuticals Inc
CEOPatel (Chintu)
Websitehttps://amneal.com/

Shareholders

Shareholders
Shareholders
Proportion
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Other
57.73%

FAQs

What is the current price of Amneal Pharmaceuticals Inc (AMRX)?

The current price of Amneal Pharmaceuticals Inc (AMRX) is 18.32.

What is the symbol of Amneal Pharmaceuticals Inc?

The ticker symbol of Amneal Pharmaceuticals Inc is AMRX.

What is the 52-week high of Amneal Pharmaceuticals Inc?

The 52-week high of Amneal Pharmaceuticals Inc is 15.42.

What is the 52-week low of Amneal Pharmaceuticals Inc?

The 52-week low of Amneal Pharmaceuticals Inc is 7.07.

What is the market capitalization of Amneal Pharmaceuticals Inc?

The market capitalization of Amneal Pharmaceuticals Inc is 5.76B.

Is Amneal Pharmaceuticals Inc (AMRX) currently rated as Buy, Hold, or Sell?

According to analysts, Amneal Pharmaceuticals Inc (AMRX) has an overall rating of Buy, with a price target of 18.84.

What is the Earnings Per Share (EPS TTM) of Amneal Pharmaceuticals Inc (AMRX)?

The Earnings Per Share (EPS TTM) of Amneal Pharmaceuticals Inc (AMRX) is 0.23.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.